Patents by Inventor Richard A. Conticello

Richard A. Conticello has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fouling mitigation of delayed coker heaters
    Patent number: 12203039
    Abstract: A method of mitigating fouling in a delayed coking unit heater may include forming a plastic mixture including a plastic material and a carrier. The plastic mixture may be combined with a coker feedstock upstream of a coke drum.
    Type: Grant
    Filed: March 8, 2023
    Date of Patent: January 21, 2025
    Assignee: AMEC FOSTER WHEELER USA CORPORATION
    Inventors: Luis Gordo, Srinivasa Srivatsan, Richard A. Conticello
  • FOULING MITIGATION OF DELAYED COKER HEATERS
    Publication number: 20230287275
    Abstract: A method of mitigating fouling in a delayed coking unit heater may include forming a plastic mixture including a plastic material and a carrier. The plastic mixture may be combined with a coker feedstock upstream of a coke drum.
    Type: Application
    Filed: March 8, 2023
    Publication date: September 14, 2023
    Inventors: Luis Gordo, Srinivasa Srivatsan, Richard A. Conticello
  • ANTIFOAMING FOR DELAYED COKER
    Publication number: 20230287273
    Abstract: A method is provided for reducing foaming within a coke drum of a delayed coking unit. The method may include forming a plastic mixture including a plastic material and a carrier. The method may also include injecting the plastic mixture into the coke drum during operation of the coke drum.
    Type: Application
    Filed: March 9, 2023
    Publication date: September 14, 2023
    Inventors: Luis Gordo, Srinivasa Srivatsan, Richard Conticello
  • Organomodified silicone fuel additive, compositions, and methods of using the same
    Patent number: 10858605
    Abstract: An organomodified silicone material is shown and described herein. The organomodified silicone provides a material that can be used as an additive in a fuel oil, e.g., diesel fuel. The organomodified silicone acts as both a defoamer and a dehazer in a fuel oil.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: December 8, 2020
    Assignee: Momentive Performance Materials Inc.
    Inventors: Narayan Mukherjee, Mark David Leatherman, Richard Conticello
  • ORGANOMODIFIED SILICONE FUEL ADDITIVE, COMPOSITIONS, AND METHODS OF USING THE SAME
    Publication number: 20190144772
    Abstract: An organomodified silicone material is shown and described herein. The organomodified silicone provides a material that can be used as an additive in a fuel oil, e.g., diesel fuel. The organomodified silicone acts as both a defoamer and a dehazer in a fuel oil.
    Type: Application
    Filed: November 7, 2018
    Publication date: May 16, 2019
    Inventors: Narayan Mukherjee, Mark David Leatherman, Richard Conticello
  • Polymeric delivery agents and delivery agent compounds
    Patent number: 7727558
    Abstract: Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: June 1, 2010
    Assignees: Emisphere Technologies, Inc., Virginia Commonwealth University
    Inventors: Sam J. Milstein, Eugene N. Barantsevitch, Nai Fang Wang, Jun Liao, John Smart, Richard Conticello, Raphael Ottenbrite
  • ACYCLIC COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    Publication number: 20100029629
    Abstract: The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, R5, Q, G, Ar, m, and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Application
    Filed: July 13, 2009
    Publication date: February 4, 2010
    Applicant: Memory Pharmaceuticals Corporation
    Inventors: Richard Conticello, Robert Dunn, Ashok Tehim, Wenge Xie
  • ALKYL-SUBSTITUTED 3' COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY
    Publication number: 20100016297
    Abstract: The present disclosure provides compounds having affinity for the 5-HT6 receptor which are of the formula (I): wherein R1, R2, Ar, m and n are as defined herein. The disclosure also relates to methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.
    Type: Application
    Filed: June 22, 2009
    Publication date: January 21, 2010
    Applicant: Memory Pharmaceuticals Corporation
    Inventors: Richard Conticello, Ruiping Liu, Ashok Tehim, Wenge Xie
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20090221661
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Application
    Filed: February 20, 2009
    Publication date: September 3, 2009
    Inventors: Allen Hopper, Erik Kuester, Robert Dunn, Richard Conticello
  • Phosphodiesterase 4 inhibitors
    Patent number: 7495017
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: February 24, 2009
    Assignee: Memory Pharmaceuticals Corporation
    Inventors: Allen Hopper, Erik Kuester, Robert Dunn, Richard Conticello
  • Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
    Publication number: 20070299067
    Abstract: The present invention is directed to certain quinoline and isoquinoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and processes for preparing such compounds. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: March 8, 2007
    Publication date: December 27, 2007
    Inventors: Ruiping Liu, Mark Arrington, Allen Hopper, Richard Conticello, Stephen Hitchcock
  • Phosphodiesterase 10 inhibitors
    Publication number: 20070287707
    Abstract: The present invention if directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compounds containing the same and processes for preparing the same. The invention is also directed to methods of treating diseases mediated by PDE10 enzyme such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: February 27, 2007
    Publication date: December 13, 2007
    Inventors: Mark Arrington, Allen Hopper, Richard Conticello, Hans-Jurgen Hess, Stephen Hitchcock
  • Quinazoline derivatives as phosphodiesterase 10 inhibitors
    Publication number: 20070265258
    Abstract: The present invention if directed to certain quinazoline compounds that are PDE10 inhibitors, pharmaceutical compounds containing the same and processes for preparing the same. The invention is also directed to methods of treating diseases treatable by PDE10 enzyme such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: March 5, 2007
    Publication date: November 15, 2007
    Inventors: Ruiping Liu, Mark Arrington, Allen Hopper, Richard Conticello, Truc Nguyen, Carla Gauss, Stephen Hitchcock
  • Phosphodiesterase 10 inhibitors
    Publication number: 20070265256
    Abstract: The present invention is directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and process for preparing such compounds. This invention is also directed to methods of treating diseases treatable by inhibition of PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: February 20, 2007
    Publication date: November 15, 2007
    Inventors: Mark Arrington, Ruiping Liu, Allen Hopper, Richard Conticello, Truc Nguyen, Carla Gauss, Roland Burli, Stephen Hitchcock, Essa Hu, Roxanne Kunz, Thomas Nixey, Shannon Rumfelt, Nign Chen
  • Cinnoline derivatives as phosphodiesterase 10 inhibitors
    Publication number: 20070265270
    Abstract: The present invention is directed to certain cinnoline compounds that are PDE10 inhibitors, pharmaceutical compositions containing such compounds and process for preparing such compounds. The invention is also directed to methods of treating diseases treatable by modulation of PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
    Type: Application
    Filed: February 20, 2007
    Publication date: November 15, 2007
    Inventors: Stephen Hitchcock, Ruiping Liu, Mark Arrington, Allen Hopper, Richard Conticello, Truc Nguyen, M. Danca, Carla Gauss
  • Phosphodiesterase 4 inhibitors
    Publication number: 20070254913
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Application
    Filed: April 19, 2007
    Publication date: November 1, 2007
    Inventors: Robert Dunn, Eric Kuester, Richard Conticello, Allen Hopper
  • Phosphodiesterase 4 inhibitors
    Publication number: 20070203197
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Application
    Filed: May 1, 2007
    Publication date: August 30, 2007
    Inventors: Allen Hopper, Erik Kuester, Robert Dunn, Richard Conticello
  • POLYMERIC DELIVERY AGENTS AND DELIVERY AGENT COMPOUNDS
    Publication number: 20070141022
    Abstract: Polymeric delivery agents, delivery agent compounds and compositions comprising them which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
    Type: Application
    Filed: January 31, 2007
    Publication date: June 21, 2007
    Inventors: Sam Milstein, Eugene Barantsevitch, Nai Wang, Jun Liao, John Smart, Richard Conticello, Raphael Ottenbrite
  • Phosphodiesterase 4 inhibitors
    Patent number: 7226930
    Abstract: Selective PDE4 inhibition is achieved by aryl and heteroaryl pyrazole compounds. The compounds exhibit improved PDE4 inhibition as compared to compounds such as rolipram and show selectivity with regard to inhibition of other classes of PDEs.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: June 5, 2007
    Assignee: Memory Pharmaceutical Corporation
    Inventors: Allen Hopper, Erik Kuester, Robert Dunn, Richard Conticello
  • Phosphodiesterase 10 inhibitors
    Publication number: 20070093515
    Abstract: Provided are certain quinazolines that are PDE10 inhibitors, pharmaceutical compositions, containing the same and processes for preparing the same. Also provided are methods of treating diseases treatable by PDE10 enzyme such as obesity, non-insulin dependent diabetes, schizophrenia or bipolar disorder, obsessive-compulsive disorder, and the like, by administering those certain quinazolines.
    Type: Application
    Filed: August 16, 2006
    Publication date: April 26, 2007
    Inventors: Mark Arrington, Richard Conticello, Carla Gauss, Stephen Hitchcock, Allen Hopper, Ruiping Liu, Truc Nguyen, Ashok Tehim